Asuragen unveils Xpansion Interpreter
Xpansion Interpreter is used to determine the number and location of AGG interruptions associated with expansion of the Fragile X gene and also helps in better understanding of
US-based biotechnology company Superluminal Medicines has completed a $60m Series B financing round to support its research into therapies for rare genetic forms of obesity and hypothalamic obesity.
Regorafenib is an oral multi-kinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases (TK) used for the treatment of metastatic colorectal cancer (mCRC). The double-blind, international, multicenter,